CRN Responds to Cholesterol Study Wrongly Comparing Supplements to Prescription Drug Rosuvastatin
CRN responds to SPORT—Poor supplement selection; inadequate length of study; potential researcher bias and unrealistic expectations plague results. Learn more from Dr. Andrea Wong.